Binding of non-steroid anti-inflammatory drugs and warfarin to liver tissue of rabbits in vitro
- 22 Downloads
Liver slices (10mm 0,1mm thickness) were incubated at 37° C in drug solutions up to 360 min. The drugs were dissolved in Ringer solution of pH 7.0. After 60, 180, 240 and 360 min each drug concentration was determined in the incubation fluid. For all drugs tested equilibrium was obtained after 240 min. The amount of drug taken up by the slices was calculated from the difference to initial concentration. In parallel, samples of the slices were homogenized together with their incubation fluids after the same incubation intervals. The free concentration was determined by ultrafiltration. For warfarin and several non-steroid anti-inflammatory drugs (NSAID), i.e. acetylsalicylic acid, ibuprofen, ketoprofen and oxyphenbutazone, there was no difference between the free drug concentrations in the homogenized and in non-homogenized samples.
This suggests that the binding of these drugs to’ liver tissue was not altered by homogenization. Further was studied whether NSAIDS interfere with binding of warfarin to liver tissue. Acetylsalicylic acid, flurbiprofen, ibuprofen, ketoprofen, oxyphenbutazone and proquazon markedly increased the free concentration of warfarin both in liver slices and homogenates (p<0.01). The extent of displacement did not differ between slices and homogenates.
Key-wordsProtein-binding Liver tissue Non-Steroid Anti-Inflammatory acetylsalicylic acid flurbiprofen ketoprofen ibuprofen oxyphenbutazone proquazon warfarin
Unable to display preview. Download preview PDF.
- 4.Goodman, L.S. and Gilman, A. (1980): The Pharmacological basis of Therapeutics.6 Ed. p. 11.Google Scholar
- 10.Kurz, H. Trunk, H., Weitz. B., (1977): Evaluation of methods to determine protein binding of drugs. Arzneim. Forsch.27 (II), 7, 1373–1380.Google Scholar
- 11.Hewitt, E.J. and Nicholas, D.J.D. (1963): Metabolic Inhibitors. A comprehensive Theatisse. Vol. II Academic Press. A.P.N. York, London.Google Scholar
- 12.Ducombe, G.W. (1963): The colorometric Micro-Determination of Long Chain Fatty Acids. Biochem. J. 88, 7–10.Google Scholar
- 13.Fujise, H. (1977): A simple and sensitive colorometric determination of ibuprofen from plasma and urine in dogs after dosing. Jap. J. vet. Sci.39, 671–73.Google Scholar
- 15.Bums, J.J., Rose, R.K., Chenkin, T., Gollman, A., Scurlet, A., Brodie, B.B. (1953): The physiological disposition of phenylbutazone in man and a method for its estimation in biological material. J. Pharmacol, exp. Ther.215, 248–53.Google Scholar
- 17.Fichtl, B., Kurz, H., (1980): Does determination of drug binding in homogenized tissue reflect binding in the intact organ. Arch. Pharmacol. 311 R3.Google Scholar
- 18.Filous, N., Fichtl, B., Kurz, H. (1976): Binding of drugs to muscle tissue. Arch. Pharmacol. 293 R 46.Google Scholar
- 20.Kurz. H. (1966): Die Permeation von Giften in die Leber. Eingeschaften der Zellmembran. Arch. Pharmac. (Naunym-Schmied.) 254, 33–44.Google Scholar
- 21.Vasko, M.R., Hug, C.C. (1972): Is the uptake of narcotic analgesics by célébrai cortical slices mediated in part by active transport? J. Pharm. Pharmac.25, 180–83.Google Scholar
- 22.Whitsett, T.L., Dayton, P.G. and McNay, J.L. (1971): The effect of hepatic blood flow on the hepatic removal rate of oxyphenbutazone in the dog. J. Pharmacol. Exp. Ther.17, 246–55.Google Scholar
- 26.Sellers, E.M. (1978): The clinical importance of interactions based on displacement of protein bound drugs. Pro. Int. Congr. Pharm.2, 896.Google Scholar
- 27.Avery, S.C. (1980): Drug Treatment Principles and Practice of clinical Pharmacology and Therapeutics. 2nd Ed ADIS press Sydney and N. York, Churchill Livingstone, p. 244, 908–910.Google Scholar